SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-054013
Filing Date
2020-11-16
Accepted
2020-11-16 07:15:51
Documents
85
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-10q_20200930.htm 10-Q 2669679
2 EX-10.1 itrm-ex101_79.htm EX-10.1 220906
3 EX-31.1 itrm-ex311_9.htm EX-31.1 19644
4 EX-31.2 itrm-ex312_8.htm EX-31.2 19953
5 EX-32.1 itrm-ex321_7.htm EX-32.1 10667
6 EX-32.2 itrm-ex322_6.htm EX-32.2 10544
  Complete submission text file 0001564590-20-054013.txt   10515151

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT itrm-20200930.xml EX-101.INS 2141160
8 XBRL TAXONOMY EXTENSION SCHEMA itrm-20200930.xsd EX-101.SCH 76381
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itrm-20200930_cal.xml EX-101.CAL 57716
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itrm-20200930_def.xml EX-101.DEF 321430
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE itrm-20200930_lab.xml EX-101.LAB 540673
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itrm-20200930_pre.xml EX-101.PRE 498245
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 201313650
SIC: 2834 Pharmaceutical Preparations